Trials / Terminated
TerminatedNCT03165188
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (actual)
- Sponsor
- NewLink Genetics Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate follow-up can be maintained for subjects who have received at least one dose of algenpantucel-L.
Conditions
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2020-12-08
- Completion
- 2020-12-08
- First posted
- 2017-05-24
- Last updated
- 2022-04-12
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03165188. Inclusion in this directory is not an endorsement.